About Overture Life
Overture Life is a biotechnology company that develops automated technologies for assisted reproductive procedures, aiming to enhance the efficiency and accessibility of in vitro fertilization (IVF). Its solutions focus on automating complex embryology lab processes, such as egg vitrification and embryo warming, to improve consistency and reduce costs. The company's DaVitri platform is designed to standardize these procedures, potentially increasing oocyte survival rates and decreasing the number of IVF cycles needed.
Company details
Funding
Total raised
$57M
Last stage
Series C
Investors
Founders
Martin Varsavsky
Serial entrepreneur and co-founder of Overture Life in 2017. Also founder of companies including Viatel, Jazztel, and Fon. Personally motivated by challenges with IVF to apply technology to fertility.
LinkedInJose Horcajadas
Co-founder of Overture Life; previously Director de laboratorio at Fundación IVI and Chief Scientific Officer at iGenomix.
Santiago Munne
Co-founder of Overture Life; pioneer in preimplantation genetic testing, founder of Reprogenetics, adjunct professor at Yale University Ob/Gyn Dept., with over 260 peer-reviewed publications.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.